Tilray Brands Inc. has announced a major expansion into the U.S. medical cannabis market following federal cannabis rescheduling. The company has launched Tilray Medical USA, Inc., aiming to lead nationwide medical cannabis innovation and growth. Tilray plans to introduce medical-grade cannabis products tailored to therapeutic needs, leveraging its global experience and compliance expertise. The expansion includes strategic collaborations with healthcare operators and professionals, positioning Tilray as a key player in the evolving U.S. medical cannabis landscape.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9604745-en) on December 18, 2025, and is solely responsible for the information contained therein.
Comments